Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Olivier, Christoph B."" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł :
Site Variation and Outcomes for Antithrombotic Therapy in Atrial Fibrillation Patients After Percutaneous Coronary Intervention.
Autorzy :
Olivier CB; Department of Medicine, Stanford Center for Clinical Research (C.B.O., K.W.M.), Stanford University School of Medicine, CA.; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany (C.B.O.).
Fan J; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Askari M; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Mahaffey KW; Department of Medicine, Stanford Center for Clinical Research (C.B.O., K.W.M.), Stanford University School of Medicine, CA.
Heidenreich PA; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Perino AC; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Leef GC; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Ho PM; Division of Cardiology, Denver VA Medical Center, CO (P.M.H.).
Harrington RA; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Department of Medicine, Center for Digital Health (R.A.H., M.P.T.), Stanford University School of Medicine, CA.
Turakhia MP; Department of Medicine (P.A.H., A.C.P., G.C.L., R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Department of Medicine, Center for Digital Health (R.A.H., M.P.T.), Stanford University School of Medicine, CA.; Division of Cardiology, Veterans Affairs Palo Alto Health Care System, CA (J.F., M.A., P.A.H., A.C.P., G.C.L., M.P.T.).
Pokaż więcej
Źródło :
Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2019 Aug; Vol. 12 (8), pp. e007604. Date of Electronic Publication: 2019 Aug 16.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Percutaneous Coronary Intervention*/adverse effects
Percutaneous Coronary Intervention*/mortality
Anticoagulants/*administration & dosage
Atrial Fibrillation/*drug therapy
Coronary Artery Disease/*therapy
Fibrinolytic Agents/*administration & dosage
Healthcare Disparities/*trends
Platelet Aggregation Inhibitors/*administration & dosage
Practice Patterns, Physicians'/*trends
Purinergic P2Y Receptor Antagonists/*administration & dosage
Stroke/*prevention & control
Aged ; Anticoagulants/adverse effects ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/mortality ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/mortality ; Drug Utilization/trends ; Female ; Fibrinolytic Agents/adverse effects ; Hemorrhage/chemically induced ; Hemorrhage/epidemiology ; Humans ; Male ; Middle Aged ; Platelet Aggregation Inhibitors/adverse effects ; Purinergic P2Y Receptor Antagonists/adverse effects ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Stroke/diagnosis ; Stroke/mortality ; Time Factors ; Treatment Outcome ; United States/epidemiology ; United States Department of Veterans Affairs ; Veterans Health
Czasopismo naukowe
Tytuł :
Central Adjudication Identified Additional and Prognostically Important Myocardial Infarctions in Patients Undergoing Percutaneous Coronary Intervention.
Autorzy :
Olivier CB; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, CA (C.B.O., K.W.M.).; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Germany (C.B.O.).
Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA (D.L.B.).
Leonardi S; University of Pavia, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy (S.L.).
Stone GW; Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY (G.W.S.).
Gibson CM; Beth Israel Deaconess Medical Center, Division of Cardiology, Boston, MA (C.M.G.).
Steg PG; FACT (French Alliance for Cardiovascular Clinical Trials), DHU FIRE, INSERM Unité 1148, Université Paris-Diderot, and Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France, and NHLI, Imperial College, Royal Brompton Hospital, London, United Kingdom (P.G.S.).
Hamm CW; Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany (C.W.H.).
Wilson MD; Duke University Medical Center, Durham, NC (M.D.W., S.M., R.D.L.).
Mangum S; Duke University Medical Center, Durham, NC (M.D.W., S.M., R.D.L.).
Price MJ; Scripps Clinic and Scripps Translational Science Institute, La Jolla, CA (M.J.P.).
Prats J; Elysis Llc, Carlisle, MA (J.P.).
White HD; Green Lane Cardiovascular Service, Auckland, New Zealand (H.D.W.).
Lopes RD; Duke University Medical Center, Durham, NC (M.D.W., S.M., R.D.L.).
Harrington RA; Department of Medicine, Stanford University School of Medicine, Stanford, CA (R.A.H.).
Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, CA (C.B.O., K.W.M.).
Pokaż więcej
Corporate Authors :
CHAMPION PHOENIX Investigators *
Źródło :
Circulation. Cardiovascular interventions [Circ Cardiovasc Interv] 2019 Jul; Vol. 12 (7), pp. e007342. Date of Electronic Publication: 2019 Jul 12.
Typ publikacji :
Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Research Design*
Adenosine Monophosphate/*analogs & derivatives
Coronary Artery Disease/*therapy
Coronary Thrombosis/*prevention & control
Myocardial Infarction/*prevention & control
Percutaneous Coronary Intervention/*adverse effects
Platelet Aggregation Inhibitors/*therapeutic use
Adenosine Monophosphate/adverse effects ; Adenosine Monophosphate/therapeutic use ; Coronary Artery Disease/complications ; Coronary Artery Disease/diagnosis ; Coronary Artery Disease/mortality ; Coronary Thrombosis/diagnosis ; Coronary Thrombosis/etiology ; Coronary Thrombosis/mortality ; Humans ; Myocardial Infarction/diagnosis ; Myocardial Infarction/etiology ; Myocardial Infarction/mortality ; Percutaneous Coronary Intervention/mortality ; Platelet Aggregation Inhibitors/adverse effects ; Randomized Controlled Trials as Topic ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Definitions of peri-procedural myocardial infarction and the association with one-year mortality: Insights from CHAMPION trials.
Autorzy :
Olivier CB; Stanford Center for Clinical Research (SCCR), Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Sundaram V; Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, MA, USA.
Leonardi S; Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy.
Lopes RD; Duke University Medical Center, Durham, NC, USA.
Ding VY; Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Yang L; Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Stone GW; Columbia University Medical Center and the Cardiovascular Research Foundation, New York City, NY, USA.
Steg PG; FACT (French Alliance for Cardiovascular clinical Trials), DHU FIRE, INSERM Unité 1148, Université Paris-Diderot, and Hôpital Bichat, Assistance-Publique-Hôpitaux de Paris, Paris, France, and NHLI, Imperial College, Royal Brompton Hospital, London, UK.
Gibson CM; Beth Israel Deaconess Medical Center, Division of Cardiology, Boston, MA, USA.
Hamm CW; Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
Price MJ; Scripps Clinic and Scripps Translational Science Institute, La Jolla, CA, USA.
White HD; Green Lane Cardiovascular Service, Auckland, New Zealand.
Desai M; Quantitative Sciences Unit, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Lynch DR Jr; University of Cincinnati College of Medicine, Cincinnati, OH, USA.
Harrington RA; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Mahaffey KW; Stanford Center for Clinical Research (SCCR), Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: .
Pokaż więcej
Corporate Authors :
CHAMPION PLATFORM and CHAMPION PCI Investigators
Źródło :
International journal of cardiology [Int J Cardiol] 2018 Nov 01; Vol. 270, pp. 96-101. Date of Electronic Publication: 2018 Jun 08.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Myocardial Infarction/*mortality
Myocardial Infarction/*surgery
Percutaneous Coronary Intervention/*mortality
Perioperative Care/*mortality
Cohort Studies ; Double-Blind Method ; Female ; Follow-Up Studies ; Humans ; Male ; Mortality/trends ; Myocardial Infarction/diagnosis ; Percutaneous Coronary Intervention/adverse effects ; Percutaneous Coronary Intervention/trends ; Perioperative Care/trends ; Time Factors
Czasopismo naukowe
Tytuł :
High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting
Autorzy :
Rilinger, Jonathan
Meyer, Melanie
Schnabel, Katharina
Weik, Patrick
Charlet, Anne
Esser, Jennifer S.
Zhou, Qian
Bode, Christoph
Moser, Martin
Diehl, Philipp
Olivier, Christoph B.
Pokaż więcej
Źródło :
Journal of Thrombosis and Thrombolysis: A Journal for Translation, Application and Therapeutics in Thrombosis and Vascular Science. November 2016 42(4):558-565
Czasopismo naukowe
Tytuł :
Evaluation of Serum Serotonin as a Biomarker for Myocardial Infarction and Ischemia/Reperfusion Injury.
Autorzy :
Rieder, Marina
Laumann, Rosmarie
Witsch, Thilo
Schanze, Nancy
Heger, Lukas
Olivier, Christoph B.
von zur Muehlen, Constantin
Bode, Christoph
Ahrens, Ingo
Lother, Achim
Duerschmied, Daniel
Hortmann, Marcus
Pokaż więcej
Temat :
REPERFUSION injury
CORONARY disease
BIOMARKERS
PERCUTANEOUS coronary intervention
CORONARY angiography
MYOCARDIAL reperfusion
Źródło :
Applied Sciences (2076-3417); Sep2020, Vol. 10 Issue 18, p6379, 1p
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies